G
GOSS
Gossamer Bio
2.46
-0.07-2.77%After Hours: 2.460 0.00 0.00%19:45 08/27 EDT
OPEN/PREV CLOSE2.530/2.530
TODAY RANGE2.450-2.645
VOL4.26M
MARKET CAP559.36M
52 WEEK RANGE0.6617-2.645
AVG VOL (3M)2.72M
% TURNOVER1.87%
TURNOVER--
P/E (TTM)-4.0209
% RANGE7.71%
EPS(TTM)-0.6118
P/E(FORWARD)-3.5396
P/B-12.1302
BVPS-0.2028
DIVIDEND--
P/S4.860
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP539.65M
SHARES OUTSTANDING227.38M
NEXT EARNINGS11/05-11/10
FREE FLOAT219.37M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
Simply Wall St·5d ago
Revenues Not Telling The Story For Gossamer Bio, Inc. (NASDAQ:GOSS) After Shares Rise 26%
TipRanks·6d ago
Director’s Bold Move: A Major Investment in Gossamer Bio
TipRanks·08/19 10:25
Gossamer Bio’s Seralutinib: Promising Long-Term Therapy with Upcoming Catalysts
TipRanks·08/12 04:12
Gossamer Bio Reports Q2 2025 Financial Results
TipRanks·08/07 12:58
Leerink Partners Sticks to Its Buy Rating for Gossamer Bio (GOSS)
Dow Jones·08/06 16:09
Gossamer Bio Is Maintained at Outperform by Wedbush
Dow Jones·08/06 16:09
Gossamer Bio Price Target Raised to $5.00/Share From $4.00 by Wedbush
Benzinga·08/06 15:59
Wedbush Maintains Outperform on Gossamer Bio, Raises Price Target to $5
Seeking Alpha·08/05 21:10
Gossamer Bio GAAP EPS of -$0.17 in-line, revenue of $11.49M beats by $6.08M
Reuters·08/05 20:01
BRIEF-Gossamer Bio Q2 EPS USD -0.17
Same Industry
Name/Symbol
Change%
Price